Farms.com Home   News

World’s Tiniest Library Could Be Key to Saving Millions of Cattle

One of the world’s smallest and strangest bacteria also is responsible for one of the most devastating cattle diseases.

The tiny bacteria, Mycoplasma mycoides subspecies mycoides (Mmm), cause contagious bovine pleuropneumonia (CBPP) when inhaled by cattle.

CBPP is a huge barrier to cattle farming in sub-Saharan Africa, where it is endemic in at least 12 countries. It is estimated to cost the continent over 38.8 million United States dollars a year.

To fully understand these deadly bacteria, and pave the way to developing a better vaccine, scientists at the International Livestock Research Institute (ILRI) are constructing a full library of their genes and their possible functions.

Cattle with CBPP develop painful and inflamed, fluid-filled lungs, causing difficulty breathing and coughing.

CBPP can infect nearly all of a herd and kill up to 50% of animals. Those that survive become weakened, and some may become chronic carriers that will breathe the bacteria onto other naive cattle.

Disease symptoms may appear several days to months following infection, so traditional methods of pastoralism and moving cattle over long distances can contribute to its spread.

Although a vaccine is available, it has limited efficacy, and sometimes causes severe side effects which can make pastoralists reluctant to use it.

Mmm are part of a class of bacteria called mollicutes. In addition to lacking a cell wall—usually a widespread feature of bacteria—mollicutes have especially small genomes, by bacterial standards.

Click here to see more...

Trending Video

How Aurora Pharmaceutical Became a Leader in Animal Health

Video: How Aurora Pharmaceutical Became a Leader in Animal Health

Dr. Michael Strobel, Founder and CEO of Aurora Pharmaceutical, discusses the company's remarkable journey from a veterinarian-led startup to a leading developer and manufacturer of animal health solutions.

In this exclusive interview, Dr. Strobel shares how Aurora Pharmaceutical was built around a simple but powerful mission: putting customers, producers, veterinarians, pet owners, and patients first. Learn how the company has grown by focusing on high-quality, science-backed, and cost-effective solutions for livestock, companion animals, and human health markets.

Discover how Aurora's commitment to innovation, affordability, and customer service continues to drive its expansion across swine, cattle, poultry, equine, companion animal, and human health sectors. Dr. Strobel also discusses the importance of understanding real-world challenges facing producers and veterinarians and how Aurora develops practical solutions that improve animal health while supporting producer profitability. Aurora's veterinarian-founded approach, commitment to American manufacturing, and focus on delivering value have helped establish the company as a trusted partner throughout the animal health industry.